Statin therapy as prevention against development of acute respiratory distress syndrome: An observational study

Critical Care Medicine

Volumn 40, Issue 5, 2012, Pages 1470-1477

  Bajwa, Ednan K ^a   Malhotra, Cindy K ^a   Thompson, B Taylor ^a   Christiani, David C ^a,b   Gong, Michelle N ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ALI ArDs; critical illness; statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

AGED; APACHE; CRITICAL ILLNESS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPENSITY SCORE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 84860259846     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182416d7a     Document Type: Article

References (43)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
3. Calfee CS, Matthay MA: Nonventilatory treatments for acute lung injury and ARDS. Chest 2007; 131:913-920
4. Stone NJ, Bilek S, Rosenbaum S: Recent National Cholesterol Education Program Adult Treatment Panel III update: Adjustments and options. Am J Cardiol 2005; 96:53E-59E.
5. Biasucci LM, Biasillo G, Stefanelli A: Inflammatory markers, cholesterol and statins: Pathophysiological role and clinical importance. Clin Chem Lab Med 2010; 48:1685-1691
6. Bosma KJ, Taneja R, Lewis JF: Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: Current and experimental approaches. Drugs 2010; 70:1255-1282
7. Muller HC, Hellwig K, Rosseau S, et al: Simvastatin attenuates ventilator-induced lung injury in mice. Crit Care 2010; 14:R143
8. Takano K, Yamamoto S, Tomita K, et al: Successful treatment of acute lung injury with pitavastatin in septic mice: Potential role of glucocorticoid receptor expression in alveolar macrophages. J Pharmacol Exp Ther 2011; 336:381-390
9. Siempos II, Maniatis NA, Kopterides P, et al: Pretreatment with atorvastatin attenuates lung injury caused by high-stretch mechanical ventilation in an isolated rabbit lung model. Crit Care Med 2010; 38:1321-1328
10. Almog Y, Novack V, Eisinger M, et al: The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med 2007; 35:372-378
11. Almog Y, Shefer A, Novack V, et al: Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110:880-885
12. Chalmers JD, Singanayagam A, Murray MP, et al: Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008; 121:1002-1007.e1
13. Donnino MW, Cocchi MN, Howell M, et al: Statin therapy is associated with decreased mortality in patients with infection. Acad Emerg Med 2009; 16:230-234
14. Kor DJ, Iscimen R, Yilmaz M, et al: Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury. Intensive Care Med 2009; 35:1039-1046
15. Shyamsundar M, McKeown ST, O'Kane CM, et al: Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009; 179:1107-1114
16. O'Neal HR Jr, Koyama T, Koehler EA, et al: Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med 2011; 39:1343-1350
17. Acute lung injury and the acute respiratory distress syndrome in Ireland: A prospective audit of epidemiology and management. Crit Care 2008; 12:R30
18. Craig TR, Duffy MJ, Shyamsundar M, et al: A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med 2011; 183:620-626
19. Gong MN, Bajwa EK, Thompson BT, et al: Body mass index is associated with the development of acute respiratory distress syndrome. Thorax 2010; 65:44-50
20. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
21. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1):818-24
22. Bernard GR, Doig G, Hudson L: Quantification of organ failure for clinical trials and clinical practice. Am J Resp Crit Care Med 1995; 151:A323
23. Brookhart MA, Schneeweiss S, Rothman KJ, et al: Variable selection for propensity score models. Am J Epidemiol 2006; 163:1149-1156
24. Kendrach MG, Kelly-Freeman M: Approximate equivalent rosuvastatin doses for temporary statin interchange programs. Ann Pharmacother 2004; 38:1286-1292
25. Nishimura T, Vaszar LT, Faul JL, et al: Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 2003; 108:1640-1645
26. Jacobson JR, Dudek SM, Birukov KG, et al: Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol 2004; 30:662-70
27. Ozansoy G, Guven C, Ceylan A, et al: Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of streptozotocindiabetic rat lung. Cell Biochem Funct 2005; 23:421-6
28. Solovey A, Kollander R, Shet A, et al: Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood 2004; 104:840-6
29. Naidu BV, Woolley SM, et al: Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg 2003; 126:482-489
30. Jacobson JR, Barnard JW, Grigoryev DN, et al: Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 288:L1026-L1032
31. Yao HW, Mao LG, Zhu JP: Protective effects of pravastatin in murine lipopolysaccharideinduced acute lung injury. Clin Exp Pharmacol Physiol 2006; 33:793-7
32. Shao H, Shen Y, Liu H, et al: Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model. Ann Thorac Surg 2007; 84:2011-2018
33. Terblanche M, Almog Y, Rosenson RS, et al: Statins: Panacea for sepsis? Lancet Infect Dis 2006; 6:242-248
34. Rosch JW, Boyd AR, Hinojosa E, et al: Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. J Clin Invest 2010; 120:627-635
35. Hackam DG, Mamdani M, Li P, et al: Statins and sepsis in patients with cardiovascular disease: A population-based cohort analysis. Lancet 2006; 367:413-418
36. Gupta R, Plantinga LC, Fink NE, et al: Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA 2007; 297:1455-1464
37. Thomsen RW, Riis A, Kornum JB, et al: Preadmission use of statins and outcomes after hospitalization with pneumonia: populationbased cohort study of 29,900 patients. Arch Intern Med 2008; 168:2081-2087
38. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
39. Frank AJ, Thompson BT: Pharmacological treatments for acute respiratory distress syndrome. Curr Opin Crit Care 2010; 16:62-68
40. Yilmaz M, Keegan MT, Iscimen R, et al: Toward the prevention of acute lung injury: Protocolguided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007; 35:1660-1666
41. Gajic O, Dabbagh O, Park PK, et al: Early identification of patients at risk of acute lung injury: Evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011; 183:462-470
42. Shari G, Kojicic M, Li G, et al: Timing to the onset of acute respiratory distress syndrome: A population-based study. Respir Care 2011; 56:576-582
43. Kruger PS, Harward ML, Jones MA, et al: Continuation of Statin Therapy in Patients with Presumed Infection: A Randomised Controlled Trial. Am J Respir Crit Care Med 201l; 183:774-781